Kentucky Alzheimer’s Researchers Step Up to Respond to Pandemic
Written By: BrightFocus Editorial Staff
Written By: BrightFocus Editorial Staff
As the global coronavirus pandemic began to hit our nation, University of Kentucky Alzheimer’s researcher Donna M. Wilcock, PhD and her team wanted to do something to help their community address the shortage of medical supplies hindering the local response.
Wilcock, who as a leading dementia scientist taught at the 2019 BrightFocus Alzheimer’s Fast Track, quickly mobilized her lab’s resources to help in this time of crisis.
“The local needs were so acute that when speaking with an official at the university’s health care system, they responded right away that they would take everything we have,” said Wilcock. “Twenty minutes later, our help was on the way.”
Wilcock’s lab shared the following resources with the local response:
With most of her lab now working remotely, Wilcock and her colleagues have put in place ways to help the team’s well-being during this pandemic, “We have a daily check-in text message to make sure everyone is okay, and to even share memes. We’ve also been having Zoom meetings to see everyone weekly.”
To support the research field during this time of great disruption, Lance Johnson, PhD, another faculty member at the University of Kentucky, has put together a virtual series of seminars featuring Alzheimer’s experts from around the world.
Wilcock and her colleagues at other Alzheimer’s centers around the nation are sharing with their patients a new a virtual guide to Alzheimer’s caregiving in a time of coronavirus.
Dr. Wilcock is the Associate Director of the Sanders-Brown Center on Aging and the Sweeney-Nelms Professor in Alzheimer’s Disease Research, both at the University of Kentucky. Her 2019 presentation to the BrightFocus Fast Track was “Vascular Contributions to Alzheimer’s Disease and Related Dementia.”
BrightFocus Foundation is a premier global nonprofit funder of research to defeat Alzheimer’s, macular degeneration, and glaucoma. Through its flagship research programs — Alzheimer’s Disease Research, Macular Degeneration Research, and National Glaucoma Research— the Foundation has awarded nearly $300 million in groundbreaking research funding over the past 51 years and shares the latest research findings, expert information, and resources to empower the millions impacted by these devastating diseases. Learn more at brightfocus.org.
Disclaimer: The information provided here is a public service of BrightFocus Foundation and is not intended to constitute medical advice. Please consult your physician for personalized medical, dietary, and/or exercise advice. Any medications or supplements should only be taken under medical supervision. BrightFocus Foundation does not endorse any medical products or therapies.